An official website of the United States government
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
Trial Status: closed to accrual
This is a multi-center, prospective, observational study of patients being treated with
ORGOVYX. The goal of this study is to generate real-world evidence about the safety and
effectiveness of ORGOVYX in patients with prostate cancer in routine clinical care and
the clinical course during treatment with and following cessation of ORGOVYX.
Inclusion Criteria
Patients who are diagnosed with prostate cancer and initiating treatment with ORGOVYX at the time of enrollment or within 1 month prior to enrollment and who remain on treatment at enrollment
Patients who are willing and able to complete PRO assessments during the study
Patients who have reviewed and signed the informed consent form (ICF)
Exclusion Criteria
Patients with a history of surgical castration
Patients with a medical or psychiatric condition that precludes participation in the opinion of the treating physician
Patients whose original treatment plan is intended to be less than a total of 4 months of ORGOVYX
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05467176.
